Virginia Economic Review

For more than 300 years, Virginia’s universities have helped produce generations of political leaders, scientists, entrepreneurs, engineers, and business executives who shaped the economy in the Commonwealth and beyond.

As the world continues to struggle with drug supply chains and critical shortages, clusters of activity have emerged to move the needle of medication affordability and accessibility.

Recent major biopharmaceutical manufacturing announcements are positioning Virginia for a broader reshoring effort in the pharma industry. COVID-era supply chain disruptions and resulting shortages exposed the risks of over-reliance on overseas production for essential medicines.